REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Shareholders' equity, 2025
- $31.3B
- YoY, 2025
- +6.5%
- 5-year CAGR
- +23.2%
- 10-year CAGR
- +23.9%
Shareholders' equity
Shareholders' equity by fiscal year
| Period | Equity | YoY |
|---|---|---|
| 2025 | $31.3B | +6.5% |
| 2024 | $29.4B | +13.0% |
| 2023 | $26.0B | +14.6% |
| 2022 | $22.7B | +20.8% |
| 2021 | $18.8B | +70.2% |
| 2020 | $11.0B | −0.6% |
| 2019 | $11.1B | +26.6% |
| 2018 | $8.8B | +42.5% |
| 2017 | $6.1B | +38.1% |
| 2016 | $4.4B | +21.7% |
| 2015 | $3.7B | +43.3% |
| 2014 | $2.6B | +30.6% |
| 2013 | $2.0B | +56.7% |
| 2012 | $1.2B | +156.4% |
| 2011 | $486M | −8.0% |
| 2010 | $528M | +33.0% |
| 2009 | $397M | −5.9% |
| 2008 | $422M | — |